Oral formulations are designed for sublingual absorption and do not require reconstitution in the traditional sense
All tissue procured has been screened by using Chagas enzyme immunoassay (EIA) test antibodies to the human immunodeficiency virus, type 1 and type 2 (anti-HIV-1 and anti-HIV-2) Plus O, Nucleic Acid Test (NAT) for HIV-1, hepatitis B surface antigen (HbsAg), hepatitis B, core total Ab, hepatitis C virus Ab (anti-HCV), cytomegalovirus (CMV) total Ab, HTLV I/II Ab, West Nile virus (WNV), ZIKA NAT, Nucleic Acid Test (NAT) for the hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HBV/HCV), syphilis, and Lyme disease
The larger of the two studies (METAOD006), which included over 500 subjects at up to 1mg/daily AOD-9604, reported the following side effects: Any adverse event: 78.7% vs
Research links low growth hormone levels and elevated DHT to hair loss
However, individual peptide-based medications and therapies have received FDA approval